- Home
- FDMT vs MAGN Comparison
FDMT vs MAGN Comparison
Compare FDMT & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- MAGN
- Stock Information
- Founded
- FDMT 2013
- MAGN 1864
- Country
- FDMT United States
- MAGN United States
- Employees
- FDMT N/A
- MAGN N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- MAGN Paper
- Sector
- FDMT Health Care
- MAGN Basic Materials
- Exchange
- FDMT Nasdaq
- MAGN Nasdaq
- Market Cap
- FDMT 391.8M
- MAGN 416.2M
- IPO Year
- FDMT 2020
- MAGN N/A
- Fundamental
- Price
- FDMT $10.81
- MAGN $8.74
- Analyst Decision
- FDMT Strong Buy
- MAGN Hold
- Analyst Count
- FDMT 9
- MAGN 1
- Target Price
- FDMT $30.11
- MAGN $12.00
- AVG Volume (30 Days)
- FDMT 933.6K
- MAGN 667.7K
- Earning Date
- FDMT 11-07-2025
- MAGN 11-20-2025
- Dividend Yield
- FDMT N/A
- MAGN N/A
- EPS Growth
- FDMT N/A
- MAGN N/A
- EPS
- FDMT N/A
- MAGN N/A
- Revenue
- FDMT $33,000.00
- MAGN $2,919,000,000.00
- Revenue This Year
- FDMT $8,572.97
- MAGN $49.20
- Revenue Next Year
- FDMT $6.05
- MAGN $5.03
- P/E Ratio
- FDMT N/A
- MAGN N/A
- Revenue Growth
- FDMT N/A
- MAGN 34.21
- 52 Week Low
- FDMT $2.24
- MAGN $8.40
- 52 Week High
- FDMT $12.34
- MAGN $23.19
- Technical
- Relative Strength Index (RSI)
- FDMT 56.19
- MAGN 37.39
- Support Level
- FDMT $10.33
- MAGN $8.43
- Resistance Level
- FDMT $12.00
- MAGN $9.11
- Average True Range (ATR)
- FDMT 0.98
- MAGN 0.41
- MACD
- FDMT -0.17
- MAGN -0.00
- Stochastic Oscillator
- FDMT 38.80
- MAGN 19.06
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About MAGN Magnera Corporation Common Stock
Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.